share_log

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

SEC ·  Aug 15, 2024 11:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more